<VariationArchive VariationID="1073342" VariationName="NM_000018.4(ACADVL):c.642_643del (p.Phe214fs)" VariationType="Deletion" Accession="VCV001073342" Version="7" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-17" DateCreated="2021-05-10" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1064374" VariationID="1073342">
      <GeneList>
        <Gene Symbol="ACADVL" FullName="acyl-CoA dehydrogenase very long chain" GeneID="37" HGNC_ID="HGNC:92" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7217125" stop="7225266" display_start="7217125" display_stop="7225266" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7120443" stop="7128585" display_start="7120443" display_stop="7128585" Strand="+" />
          </Location>
          <OMIM>609575</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000018.4(ACADVL):c.642_643del (p.Phe214fs)</Name>
      <CanonicalSPDI>NC_000017.11:7221969:TCT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7221970" stop="7221971" display_start="7221970" display_stop="7221971" variantLength="2" positionVCF="7221969" referenceAlleleVCF="TTC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7125289" stop="7125290" display_start="7125289" display_stop="7125290" variantLength="2" positionVCF="7125288" referenceAlleleVCF="TTC" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>NM_000018.4(ACADVL):c.642_643del</Name>
        <Name>p.Phe214fs</Name>
      </OtherNameList>
      <ProteinChange>F138fs</ProteinChange>
      <ProteinChange>F192fs</ProteinChange>
      <ProteinChange>F214fs</ProteinChange>
      <ProteinChange>F237fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.7125290_7125291del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.7125290_7125291del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.7221971_7221972del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.7221971_7221972del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007975.1" sequenceAccession="NG_007975" sequenceVersion="1" change="g.7138_7139del">
            <Expression>NG_007975.1:g.7138_7139del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008391.2" sequenceAccession="NG_008391" sequenceVersion="2" change="g.3080_3081del">
            <Expression>NG_008391.2:g.3080_3081del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000018.4" sequenceAccession="NM_000018" sequenceVersion="4" change="c.642_643del" MANESelect="true">
            <Expression>NM_000018.4:c.642_643del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000009.1" sequenceAccession="NP_000009" sequenceVersion="1" change="p.Phe214fs">
            <Expression>NP_000009.1:p.Phe214fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001033859.3" sequenceAccession="NM_001033859" sequenceVersion="3" change="c.576_577del">
            <Expression>NM_001033859.3:c.576_577del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001029031.1" sequenceAccession="NP_001029031" sequenceVersion="1" change="p.Phe192fs">
            <Expression>NP_001029031.1:p.Phe192fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001270447.2" sequenceAccession="NM_001270447" sequenceVersion="2" change="c.711_712del">
            <Expression>NM_001270447.2:c.711_712del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001257376.1" sequenceAccession="NP_001257376" sequenceVersion="1" change="p.Phe237fs">
            <Expression>NP_001257376.1:p.Phe237fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001270448.2" sequenceAccession="NM_001270448" sequenceVersion="2" change="c.414_415del">
            <Expression>NM_001270448.2:c.414_415del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001257377.1" sequenceAccession="NP_001257377" sequenceVersion="1" change="p.Phe138fs">
            <Expression>NP_001257377.1:p.Phe138fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1186576451" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000018.4(ACADVL):c.642_643del (p.Phe214fs) AND Very long chain acyl-CoA dehydrogenase deficiency" Accession="RCV001386322" Version="7">
        <ClassifiedConditionList TraitSetID="417">
          <ClassifiedCondition DB="MedGen" ID="C3887523">Very long chain acyl-CoA dehydrogenase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2022-12-14" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-12-14" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2021-05-10" MostRecentSubmission="2024-06-17">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11590124</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9973285</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/2b712c1a-a7fc-4ff4-8314-e2abd6f5a774</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="417" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="27" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">VLCAD deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Very long chain acyl-CoA dehydrogenase deficiency</ElementValue>
                <XRef ID="VLCAD+deficiency/7410" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008723" DB="MONDO" />
                <XRef ID="237997005" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">VLCAD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">ACADVLD</ElementValue>
                <XRef Type="MIM" ID="201475" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VLCADD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Deficiency of very long-chain acyl-coenzyme A dehydrogenase (VLCAD), which catalyzes the initial step of mitochondrial beta-oxidation of long-chain fatty acids with a chain length of 14 to 20 carbons, is associated with three phenotypes. The severe early-onset cardiac and multiorgan failure form typically presents in the first months of life with hypertrophic or dilated cardiomyopathy, pericardial effusion, and arrhythmias, as well as hypotonia, hepatomegaly, and intermittent hypoglycemia. The hepatic or hypoketotic hypoglycemic form typically presents during early childhood with hypoketotic hypoglycemia and hepatomegaly, but without cardiomyopathy. The later-onset episodic myopathic form presents with intermittent rhabdomyolysis provoked by exercise, muscle cramps and/or pain, and/or exercise intolerance. Hypoglycemia typically is not present at the time of symptoms.</Attribute>
                <XRef ID="NBK6816" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5508" />
                <XRef ID="5508" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301763</ID>
                <ID Source="BookShelf">NBK6816</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="GMDI/SERN, 2021">
                <URL>https://managementguidelines.net/guidelines.php/130/VLCAD%20Nutrition%20Guidelines/Version%201.1</URL>
                <CitationText>VLCAD Nutrition Management Guidelines</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C14.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C14:1 +/- other long-chain acylcarnitines, Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="GMDI, 2022">
                <URL>https://managementguidelines.net/guidelines.php/146/VLCAD%20Nutrition%20Guidelines/Version%201.4</URL>
                <CitationText>GMDI (SERN), VLCAD Nutrition Management Guidelines, v. 1.4, 2022</CitationText>
              </Citation>
              <XRef ID="26793" DB="Orphanet" />
              <XRef ID="C3887523" DB="MedGen" />
              <XRef ID="MONDO:0008723" DB="MONDO" />
              <XRef Type="MIM" ID="201475" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="5418014" SubmissionDate="2023-03-31" DateLastUpdated="2023-04-15" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="2b712c1a-a7fc-4ff4-8314-e2abd6f5a774" localKeyIsSubmitted="1" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV002769763" DateUpdated="2023-04-15" DateCreated="2022-12-31" Type="SCV" Version="2" SubmitterName="ClinGen ACADVL Variant Curation Expert Panel, ClinGen" OrgID="508473" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-14">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/2b712c1a-a7fc-4ff4-8314-e2abd6f5a774</URL>
          </Citation>
          <Comment>The c.642_643del (p.Phe214LeufsTer38) variant in ACADVL is a frameshift variant predicted to cause a premature stop codon in biologically-relevant-exon 9/20 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMIDs 9973285, 11590124). At least one patient with this variant displayed increased acylcarnitine levels, which is highly specific for very long chain acyl CoA dehydrogenase (VLCAD) deficiency (PP4, PMID: 31620161). Additionally, two individuals carried a distinct likely pathogenic variant not confirmed to be in trans, but one of these individuals was not confirmed by biochemical testing to be affected with VLCAD deficiency (PMID: 35400565). The highest population minor allele frequency in gnomAD v3.1.2 is 0.00001470 in European (non-Finnish) population, which is lower than the ClinGen ACADVL Variant Curation Expert Panel threshold (&lt;0.001) for PM2_Supporting, meeting this criterion (PM2_Supporting). In summary, this variant meets the criteria to be classified as pathogenic for autosomal recessive VLCAD deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: PVS1, PM2_Moderate, PP4 (ACADVL VCEP specifications version 1; approved November 8, 2021).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">clingen acadvl acmg specifications v1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/iz6xgwit/clingen_acadvl_acmg_specifications_v1.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACADVL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000018.4(ACADVL):c.642_643del</Name>
            <Name>p.Phe214fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.11:g.7221971_7221972del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0008723" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>ACADVL VCEP December Batch</SubmissionName>
          <SubmissionName>SUB13008499</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3112159" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="8846097|MedGen:C3887523" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001586510" DateUpdated="2024-02-20" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-01-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9973285</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11590124</ID>
          </Citation>
          <Comment>This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in ACADVL are known to be pathogenic (PMID: 9973285, 11590124). This variant has not been reported in the literature in individuals with ACADVL-related conditions. This sequence change creates a premature translational stop signal (p.Phe214Leufs*38) in the ACADVL gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACADVL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.7125289_7125290del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3887523" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9816444" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="NM_000018.4:c.642_643del|OMIM:201475" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005058236" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000018.4:c.642_643del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="201475" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9816444" TraitType="Disease" MappingType="XRef" MappingValue="201475" MappingRef="OMIM">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3112159" TraitType="Disease" MappingType="XRef" MappingValue="C3887523" MappingRef="MedGen">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5418014" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0008723" MappingRef="MONDO">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

